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Summary statement 
A genome-wide RNAi screen, in Drosophila, identifies MASK as a positive 
regulator of the JAK/STAT signalling via stabilisation of the pathway receptor - 
a function conserved in human cells. 
Abstract 
Cytokine receptors often act via the Janus Kinase and Signal Transducer and 
Activator of Transcription (JAK/STAT) pathway to form a signalling cascade 
essential for processes such as haematopoiesis, immune responses and 
tissue homeostasis. In order to transduce ligand activation, cytokine receptors 
must dimerise. However, mechanisms regulating their dimerisation are poorly 
understood. In order to better understand the processes regulating cytokine 
receptor levels, activity and dimerisation, we used the highly conserved 
JAK/STAT pathway in Drosophila, which acts via a single receptor, known as 
Domeless. We have performed a genome-wide RNAi screen in Drosophila 
cells, identifying MASK as a positive regulator of Domeless dimerisation and 
protein levels. We show that MASK is able to regulate receptor levels and 
JAK/STAT signalling both in vitro and in vivo. We also show that the human 
homologue, ANKHD1, is also able to regulate JAK/STAT signalling and the 
levels of a subset of pathway receptors in human cells. Taken together, our 
results identify MASK as a novel regulator of cytokine receptor levels, and 
suggest functional conservation, which may have implications for human 
health. 
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Introduction 
The ability to bind to extracellular ligands and transduce the resulting 
interaction across the plasma membrane represents the central biological 
function of cytokine receptors. Such receptors include the single-pass 
transmembrane proteins that ultimately stimulate the Janus Kinase and Signal 
Transducer and Activator of Transcription (JAK/STAT) pathway (Arbouzova 
and Zeidler, 2006, Vainchenker and Constantinescu, 2013). This group of 
receptors are typically homo- or hetero-dimerised with an extracellular 
structure consisting of multiple Fibronectin Type III repeats in which two of the 
distal repeats form a cytokine binding motif (Tanaka et al., 2014) (CBM; Fig 
1A). On the C-WHUPLQDOLQWUDFHOOXODUVLGHORQJȕ-type cytokine receptors, such 
as Glycoprotein 130 (GP130), Oncostatin M Receptor B (OSMRB), 
Thromobopoietin Receptor (TPOR) and the Drosophila receptor Domeless 
(Dome), contain juxta-membrane domains via which cytosolic JAK tyrosine 
NLQDVHVDVVRFLDWH%\FRQWUDVWVKRUWHUĮ-type receptors such as Interleukin 
(IL)-5ĮSDUWLFLSDWHLQWKHIRUPDWLRQRIOLJDQGELQGLQJFRPSOH[HVEXWODFNWKH
intracellular domains bound by downstream pathway components (Heinrich et 
al., 2003). 
Cytokine binding to the extracellular domains of a receptor complex induces a 
conformational change, which either reorients a preformed dimer (Brown et 
al., 2005, Remy et al., 1999) or induces receptor dimerisation/oligomerisation 
(Thomas et al., 2011). In the case of Erythropoietin (EPO), ligand binding has 
been shown to be sufficient to bring about receptor dimerisation (Boger and 
Goldberg, 2001) while the related receptor in Drosophila, Domeless (Dome), 
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is dimerised in vivo via a ligand and JAK/STAT pathway-independent 
mechanism (Brown et al., 2003). 
In canonical JAK/STAT pathway signalling, this activation results in JAK auto-
phosphorylation, followed by trans-phosphorylation of intracellular tyrosine 
residues in the receptor tail and recruitment of latent STAT molecules 
(Vainchenker and Constantinescu, 2013). These STATs are then themselves 
tyrosine phosphorylated, dimerise and translocate to the nucleus where they 
bind to palindromic DNA sequences in the promoters of pathway target genes 
and thus regulate gene expression. 
In humans, JAK/STAT pathway signalling is mediated by 4 JAKs and 6 
STATs, playing key roles both during embryonic development, adult 
homeostasis and multiple diseases (Arbouzova and Zeidler, 2006, 
Vainchenker and Constantinescu, 2013). These core components are 
themselves downstream of multiple receptors and ligands with cell-specific 
differences, redundancy and cross talk between pathway components making 
the dissection of signalling processes particularly challenging. For example, 
signalling by the pro-inflammatory cytokine IL-6, occurs via receptor 
KHWHURGLPHUVPDGHXSRIWKHORQJȕ-W\SH*3UHFHSWRUDQGWKHVKRUWHUĮ-
type IL-6R, with both membrane-bound and soluble forms of IL-6R able to 
form signalling competent complexes with GP130 to stimulate the 
downstream pathway (Tanaka et al., 2014). By contrast, the production of 
erythrocytes and platelets is dependent on homo-dimerised EPO Receptor 
(EPOR) and TPOR respectively, receptors which function upstream of JAK2 
and STAT5 (Seubert et al., 2003).  
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Although the core JAK and STAT pathway components have been 
extensively studied, the regulatory processes controlling upstream pathway 
receptors are less well understood. One key mechanism regulating receptor 
levels at the plasma membrane is endocytosis. Originally considered as a 
mechanism to attenuate pathway signalling following activation (Liu and 
Shapiro, 2003), it is now clear that the endocytosis and trafficking of 
ligand:receptor complexes into endosomes, and continued pathway signalling 
from this internalised compartment, not only occurs, but is also frequently 
qualitatively changed (reviewed in (Cendrowski et al., 2016). Although 
uncertainty remains, changes in the micro-environment within a maturing 
endosome such as reduced pH, trapping of the ligand, alterations in the 
receptor complex and changes to ligand:receptor affinities are all likely to 
occur (Kurgonaite et al., 2015). Indeed there is compelling evidence that even 
closely related receptors, Interferon (IFN) type I and type II, are regulated 
through varying mechanisms (de Weerd and Nguyen, 2012). Ultimately, 
receptor recycling to the plasma membrane or destruction of the complex 
within the lysosome also changes the levels of functional receptors (Chmiest 
et al., 2016, Gesbert et al., 2004). 
In order to better understand the processes regulating cytokine receptor 
levels, activity and dimerisation, we set out to exploit the lower complexity of 
the Drosophila JAK/STAT signalling pathway which consists of a single JAK 
and STAT-like molecule together with a single full-length receptor, Dome, and 
a single short antagonistic receptor, termed Latran [also known as Eye 
Transformer] (reviewed in (Zeidler and Bausek, 2013). Using this system we 
undertook an RNA-interference (RNAi)-based screens for regulators of the 
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Dome receptor. A previous report indicated that JAK/STAT pathway activation 
downstream of the Dome receptor requires homo-dimerisation of the receptor 
(Brown et al., 2003). Furthermore, it showed that dimerisation is 
developmentally regulated by an as-yet unidentified ligand- and signalling-
independent mechanism in vivo. In this study, we employed a molecular 
complementation assay utilisLQJ WZR WUXQFDWHG IRUPV RI WKH ȕ-galactosidase 
ȕ-JDOHQ]\PHWHUPHGǻĮDQGǻȦ (Rossi et al., 1997) and fused these to the 
cytosolic, C-terminal ends of the Dome receptor. Although enzymatically 
inactive in isolation, dimerisation of two Dome molecules brings together both 
a ǻĮ and a ǻȦ truncation, allowing molecular complementation and the 
UHFRQVWLWXWLRQRIȕ-gal activity (Fig. 1A). 
Here we present our use of such a molecular complementation assay to 
undertake RNAi screens for factors able to modulate Dome levels and/or 
dimerisation. We present our genome-wide analysis of this screen and go on 
to follow up by analysing the conserved, Multiple Ankyrin repeats and KH-
domain containing protein, MASK. Using both biochemical and genetic 
approaches, we show that MASK promotes Dome dimerisation and stability 
and demonstrate that JAK/STAT pathway activity is reduced following MASK 
knockdown. We go on to demonstrate that MASK binds directly to the Dome 
receptor via its medial A2 cluster of Ankyrin repeats and stabilise the resulting 
complex. We show that the conserved human homologue, ANKHD1, is also 
able to regulate both JAK/STAT pathway activity and the stability of a subset 
of human cytokine receptors. This study therefore identifies a novel regulator 
of cytokine receptor levels providing insights into the regulation of this 
disease-relevant signalling pathway.  
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 Results 
$VSOLWȕ-galactosidase assay for monitoring receptor dimerisation 
Genome-scale RNAi screening has previously identified multiple regulators of 
JAK/STAT transcriptional activity (Kallio et al., 2010, Müller et al., 2005). 
However, changes in gene expression do not provide insights into the 
molecular mechanisms via which regulators of the pathway act. We therefore 
modified an assay for Dome dimerisation XVLQJDVSOLWȕ-gal complementation 
system (Brown et al., 2003), in wKLFKWKHFRGLQJUHJLRQIRUWKHȕ-gal enzyme 
containing one of two inactivating deletions (termed ǻĮDQGǻȦ) was attached 
to the intracellular terminus of the Dome receptor (Fig. 1A). The ǻĮ and  
fragments are themselves unable to complement unless they are brought into 
close proximity by fusing them to proteins that physically interact (Rossi et al., 
1997). As previously demonstrated in vivo (Brown et al., 2003), each 
LQGLYLGXDO ȕ-gal fusion protein is inactive in isolation and shows enzymatic 
activity only when co-expressed in the same cells (Fig. S1A). Thus we note 
that all combinations of tagged Dome reFHSWRU FDQ GLPHULVH HJ 'RPHǻĮ
:DomeǻĮ), but homodimers ZLOO QRW EH GHWHFWHG DV KDYLQJ ȕ-gal activity. 
However, since all dimer combinations are assumed to form with equal 
probability, the detectable population of heterodimers are representative of 
the overall population of all dimerised molecules. We adapted this technique 
for use in cultured Drosophila cells (Fig. 1B) and optimised a luminescent 
UHDGRXW IRU ȕ-gal enzymatic activity (Fig. S1A and Materials and Methods). 
Although designed to detect receptor dimers, our assay was also inherently 
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sensitive to the absolute level of these dimers, since any changes in the 
amount of protein wRXOGDOVRUHVXOWLQFKDQJHVLQȕ-gal activity. 
A genome-wide RNAi screen identifies modulators of Dome dimerisation 
and stability 
We performed a genome-wide RNAi screen using a second generation, in 
silico optimised, double-stranded RNA (dsRNA) library targeting 97.9% of the 
Drosophila genome (Fig. 1C, Fig. S1B) and analysed the resulting >110k data 
points using best practice analysis techniques (Fisher et al., 2012). To avoid 
variation in transfection efficiency, which could affect results in the assay, we 
transfected a single batch of pooled cells that was aliquoted across a whole 
genome replicate. As expected, negative controls (targeting GFP or the 
C.elegans gene zk686.3) did not significantly affect our assay while 
knockdown of the endocytic trafficking component rab5 increased levels of 
dimerised Dome, consistent with previous reports (Stec et al., 2013, Vidal et 
al., 2010). Conversely, knockdown of either dome itself or lacZ strongly 
GHFUHDVHG ȕ-gal activity (Fig. 1D; Fig. S1B). Using techniques previously 
developed for similar genome-scale screens (Fisher et al., 2012, Müller et al., 
2005), we first analysed three replicates of initial screening [available via 
GenomeRNAi (http://www.genomernai.org)] and then identified potential hits, 
which we subsequently retested in secondary re-screens (Table S1). Based 
on both primary and secondary screening, 43 candidates with consistent and 
robust Z-scores were selected for further analysis (Table 1; see Materials & 
Methods for precise selection criteria). Previous work undertaken in vivo 
suggested that ligand expression is not sufficient for Dome dimerisation 
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(Brown et al., 2003). To test this finding in the context of our 43 candidates, 
we repeated the original Dome dimerisation assay in the presence of co-
expressed pathway ligand and found that most (79%, 34/43) of the original 
hits reproduced their effects (Table 1). In addition, it has also been shown that 
Dome can form hetero-dimers with the short negatively acting pathway 
receptor Latran (Lat), and that Lat can also form homodimers with itself 
(Fisher et al., 2016, Makki et al., 2010). We therefore set up cell based assays 
to test for Dome:Lat heterodimer and Lat:Lat homodimer formation and used 
this to test the 43 candidate genes. We found that 90% (36/40) of candidates 
affect Dome:Lat and Lat:Lat dimers, with 31 of these common to both (Table 
1).  
Although our molecular complementation assay requires receptor dimerisation 
WR SURGXFH ȕ-gal enzymatic activity, changes in signal can also be a 
consequence of changes in overall receptor levels due to alterations in gene 
expression level, mRNA stability or protein stability/turnover. In order to 
distinguish between those hits that promote or inhibit dimerisation and those 
that simply change protein levels, we next sought to quantify total protein 
levels using an independent technical approach. We therefore used quantified 
Western blotting undertaken in triplicate (see Materials and Methods for assay 
design) to examine the effects of the 43 genes on overall Dome protein levels. 
Of the candidates tested, 31 altered Dome protein levels by at least 25% 
(Table 1, also see Fig. S1C-D for examples) while the remaining 13 appear to 
change dimerisation without affecting overall protein levels. It should be noted 
that this secondary assay used a different form of tagged Dome and so 
protein concentration cannot be directly compared to quantitative changes in 
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WKH HQ]\PDWLF DFWLYLW\ RI ȕ-gal measured in the original screen (i.e. a 25% 
change in protein levels would not necessarily relate to a 25% change in 
luciferase values). 
Given the changes in Dome dimerisation and protein levels we also assessed 
the effect of our hits on JAK/STAT dependent transcription using the 
6x2xDrafLuc reporter (Müller et al., 2005). Surprisingly, while gene 
knockdown by some dsRNAs clearly affected JAK/STAT transcriptional 
activity, a large proportion had little or no effect on the 6x2xDrafLuc reporter 
(Table 1). This rather unexpected result suggests that either the levels of 
dimerised receptor are not rate limiting in this system, or that alternative 
regulatory pathways are able to compensate for changes in Dome dimer 
activity. 
We next undertook an analysis of our 43 candidates to identify gene 
ontological terms disproportionately enriched or depleted relative to the whole 
Drosophila genome (Mi et al., 2017). This identified strong overrepresentation 
of genes involved in endocytosis (GO:0006897), actin cytoskeleton 
(GO:0015629), and cellular component morphogenesis (GO:0032989). 
One striking GO group identified were Actin-related proteins initially identified 
as strong hits, a group of hits which also resulted in significant up-regulation 
of Dome protein levels (Table 1 and Fig. S1E). Upon further examination by 
qPCR, we found that RNAi-mediated knockdown of Act42A resulted in a 
significant increase in the transcription of Dome construct transfected into our 
cells and expressed by an actin5c-derived promoter (Fig. S1F). Given that this 
result indicated the existence of a feedback loop regulating the Actin promoter 
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used in this construct, Actin-related genes were classified as non-specific in 
this assay. 
MASK regulates levels of dimerised Dome 
Throughout the multiple rounds of screening and secondary assays 
undertaken, RNAi targeting MASK consistently generated strong effects on 
the dimerisation assay, receptor levels and JAK/STAT pathway transcriptional 
activity (bolded in Table 1). We therefore, set out to better investigate the 
mechanisms underlying this activity. 
In order to confirm the screen-based identification of MASK, we retested its 
effect using an alternative dimerisation assay. Using co-immunoprecipitation 
of differentially epitope tagged Dome molecules followed by quantification of 
western blots, we found that knockdown of MASK was sufficient to reduce 
Dome dimerisation by 50% (± 10%, p<0.013, n=3) (Fig. 2A). Furthermore, 
given the nature of immunoprecipitation experiments, this approach is 
independent of potential protein level changes and therefore represents a 
specific assay for Dome:Dome dimerisation. In order to assess whether 
MASK knockdown also altered Dome-FLAG protein levels, we returned to our 
semi-quantitative western blotting secondary assay. This allowed us to 
confirm that change in Dome dimerisation, due to MASK knockdown, was 
also accompanied by an approximate 25% decrease in the steady state level 
of Dome protein detected (Fig. 2B). As such, knockdown of MASK resulted in 
both the destabilisation of Dome:Dome dimers and also a reduction in the 
absolute levels of Dome itself.  
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Consistent with the decrease in levels and dimerisation of receptor, we also 
found that Upd-induced JAK/STAT transcriptional activation was reduced 
following knockdown of MASK, both at the level of a luciferase-based 
JAK/STAT-sensitive reporter (Table1) and also via the reduction in 
transcription of the STAT92E target gene, SOCS36E (Fig. 2C). This result 
was confirmed using two independent dsRNAs, each of which reduced both 
MASK mRNA by >70% (Fig. S2A), and pathway-induced transcription (Fig. 
S2B). The requirement for MASK in JAK/STAT signalling was further 
demonstrated using two additional independent STAT92E reporter assays, 
each of which was strongly and significantly reduced following MASK 
knockdown (Fig. S2C). Taken together, these findings confirm that MASK 
functions as a positive regulator of the Drosophila JAK/STAT pathway. 
Previous reports have identified MASK as a regulator of the Ras/Raf and 
Hippo/Warts pathways (Sansores-Garcia et al., 2013, Sidor et al., 2013, Smith 
et al., 2002), we examined the effects of silencing known components of the 
Ras (csw, ras85D, ras64B, raf) and Hippo (hpo, wts, yki) pathways in order to 
identify potential pathway cross-talk with our JAK/STAT pathway assays. 
Analysed as Z-scores relative to the original genome-wide screen dataset, 
neither Dome dimerisation, stability (Fig. S2D) nor STAT92E transcriptional 
activity (Fig. S2E) were significantly affected by knockdown of any of the Ras 
or Hippo pathway components tested. This suggests that MASK is acting 
directly on the JAK/STAT pathway. 
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MASK regulates JAK/STAT signalling in vivo 
In order to support the cell and RNAi-based data, we also undertook in vivo 
JAK/STAT pathway assays using previously characterised loss-of-function 
MASK alleles (Smith et al., 2002). Ectopic JAK/STAT pathway activation is 
sufficient to drive over-proliferation within the developing eye imaginal disc, a 
process that is sensitive to downstream JAK/STAT pathway activity (Fig. 2D-
E) (Bach et al., 2003, Mukherjee et al., 2006). Using this test, we found that 
JAK/STAT pathway-induced eye overgrowth was markedly reduced in genetic 
backgrounds heterozygous for independent MASK loss-of-function alleles 
(Fig. 2F and Fig. S2F-H).  
We next explored whether MASK was required to maintain Dome protein 
levels in vivo. Since existing MASK mutant alleles are embryonic lethal, we 
induced mitotic clones of either the hypomorphic allele MASK7.29 or the null 
MASK10.22 allele in developing wing discs (Fig. 2G-H). In the absence of 
reliable antibodies against Dome, we ubiquitously expressed epitope-tagged 
Dome-V5 throughout the wing disc using tubulin-GAL4 (Fig. 2G). As observed 
previously (Makki et al, 2010), Dome was found to accumulate in intracellular 
vesicles, with weak staining observed at the plasma membrane. Although 
MASK mutant clones proliferate poorly and are therefore relatively small, 
levels of Dome detected in mutant areas are significantly lower than in 
surrounding wild type tissue (Fig. 2G-I). When Dome levels inside clones 
(which are identified by their lack of GFP marker expression) were quantified 
relative to equivalent neighbouring, wild-type regions, a significant reduction in 
Dome-V5 levels was observed for both MASK alleles (Fig. 2H,I). By contrast 
another single pass transmembrane protein E-cadherin (E-cad), which is not a 
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JAK/STAT pathway receptor, is unaffected by loss of MASK. Given that 
transcription of Dome in this experiment is driven via a uniformly expressed 
heterologous tubulin promoter, we conclude that changes in Dome are a 
function of reduced protein levels rather than a change in gene expression. 
These results suggest that MASK acts as a positive regulator of the 
JAK/STAT pathway in vivo in Drosophila and is able to modulate pathway 
receptor levels. 
MASK can physically associate with Dome 
Given the ability of ankyrin repeats to mediate protein:protein interactions 
(Bennett and Chen, 2001, Michaely et al., 1999) and given the ability of 
Drosophila MASK to modulate Dome receptor levels, we reasoned that MASK 
proteins may directly bind to cytokine receptors. We therefore utilised 
constructs encoding each of the ankyrin repeat domains and the KH domain 
of MASK (Sansores-Garcia et al., 2013), expressed these in Drosophila Kc167 
cells (Fig. 3A) and tested these for binding to Dome. We found that the 
MASK-A2 and, more weakly, the MASK-A1 ankyrin repeat domains were able 
to co-precipitate Dome-FLAG (Fig. 3B). Although no interaction was detected 
with the MASK-KH region, we are unable to rule out binding due to much 
lower expression levels of the MASK-KH fragment (Fig. 3B). The interaction 
with MASK ankyrin repeat domains was found to be reciprocal, with a FLAG-
tagged construct containing both ankyrin repeat domains (MASK-A1A2; Fig 
3A) being immunoprecipitated with Dome-HA (Fig. 3C). 
These results suggest that MASK forms a physical complex with Dome and 
suggests that this interaction occurs via its ankyrin repeat domains. 
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Increased MASK levels leads to raised receptor levels 
Given the negative effect of RNAi-mediated MASK knockdown on receptor 
stability, we tested whether increased levels of MASK fragments might have 
the opposite effect. In contrast to loss-of-function experiments, we found that 
expression of the second MASK ankyrin repeat cluster (MASK-A2; Fig. 3A) 
(Sansores-Garcia et al., 2013) was sufficient to increase the steady state 
levels of Dome in Kc167 cells (Fig. 3D), while over expression of exogenous 
Dome was also sufficient to reciprocally stabilise MASK-A1A2 (Fig. 3E). 
These results support the initial finding that MASK is a positive regulator of 
Dome stability and, when taken together with the physical interactions 
between Dome and MASK, suggest that Dome:MASK association forms a 
stabilised protein complex.  
Conservation of MASK function in human cells 
Since MASK has been evolutionarily conserved between humans and 
Drosophila at the primary sequence level (Fig. 4A), we tested whether its 
function in modulating JAK/STAT signalling is also conserved. To test the 
effects of knocking down the closely related ANKHD1 on the human 
JAK/STAT pathway, we used qPCR in HeLa cells to detect the mRNA of the 
pathway target gene, SOCS3 (Murray, 2007). As expected, mRNA levels of 
SOCS3 were strongly decreased following silencing of JAK2 and STAT3 while 
siRNA-mediated silencing of ANKHD1 (whose efficiency is shown in Fig. S3A) 
was also sufficient to significantly reduce expression (Fig. 4B). Consistent with 
this, ANKHD1 knockdown was also sufficient to significantly reduce the OSM-
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stimulated phospho-STAT1 and phospho-STAT3 levels, a hallmark of 
pathway activation (Fig. 4C and Fig. S3B).  
Given that knockdown of Drosophila MASK led to a reduction in Dome protein 
levels (Fig. 2B, 2G) we tested cytokine receptor levels in human cells. 
Strikingly, while knockdown of ANKHD1 had no detectable effect on 
Leukaemia Inducible Factor Receptor (LIFR), it led to the almost complete 
loss of the endogenous GP130, the long cytokine receptor central to IL6-class 
cytokine receptor complexes (Fig. 4D) (Heinrich et al., 2003). Given that the 
change in GP130 protein level could be the consequence of changes in 
protein stability, mRNA stability or transcriptional regulation, we tested the 
ability of ANKHD1 to alter the levels of HA-tagged TPOR and EPOR 
expressed from a CMV promoter in HeLa cells in the presence or absence of 
ANKHD1. Both receptors were greatly reduced following treatment with 
ANKHD1 siRNA (Fig. 4E,F). Since these receptors were expressed from a 
constitutive promoter, they are unlikely to be affected by changes in 
transcriptional control, further supporting a model in which ANKHD1 functions 
at a post-transcriptional level. 
Taken together, these results suggest that the human homologue of MASK, 
ANKHD1, also acts as a positive regulator of JAK/STAT signalling and 
modulates the levels of a subset of human cytokine receptors. 
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 Discussion 
The development, and maintenance of multicellular life is absolutely 
dependent on the ability of cells to communicate with one-another ± a process 
that requires transmembrane receptor molecules. In this report we have 
undertaken a screen to identify the factors involved in the dimerisation and 
stability of the Drosophila receptor associated with JAK/STAT pathway 
activation. This single pass, trans-membrane receptor, termed Dome, forms 
homo-dimers in a spatially and temporally restricted manner during embryonic 
development. This dimerisation is required for downstream signalling, but is 
unaffected by the presence of the pathway ligand Unpaired (Brown et al., 
2003). More recently, a related, but shorter receptor, termed Latran, was 
identified which acts negatively to down-regulate JAK/STAT pathway 
signalling (Kallio et al., 2010, Makki et al., 2010). Strikingly, Latran has also 
been shown to be able to form both homo-dimers and hetero-dimers with 
Dome (Fisher et al., 2016, Makki et al., 2010) with the formation of signalling-
incompetent Dome:Lat heterodimers thought to represent the mechanism of 
negative regulation (Fisher et al., 2016). However, while the receptors 
themselves have been characterised, the mechanisms mediating receptor 
dimerisation required to generate a signalling-competent complex are 
unknown. As such, the data reported here represents the first comprehensive 
description of the components required for this process. 
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2QHFDYHDWRI WKHVFUHHQGHVLJQSUHVHQWHG LV WKH IDFW WKDW WKHȕ-gal activity 
measured is influenced by both the efficiency of dimer formation and the 
stability/levels of Dome protein ± although we are able to rule out effects on 
transcriptional regulation due to the use of a ubiquitous actin promoter. In 
order to differentiate between these two influences, we undertook secondary 
screens using semi-quantitative Western blotting to assess protein levels. In 
this way we differentiated between those genes modulating dimerisation, 
those modulating protein levels and those that regulate both aspects. Based 
RQ WKLV LQVLJKW WKH LGHQWLILFDWLRQ RI KLWV WKDW FKDQJH ȕ-gal activity and NOT 
protein levels (e.g. VHFȕ and CG6106) suggest that failure to dimerise does 
not inherently affect protein stability. By contrast, hits such as MASK that 
change both dimerisation and protein levels may be affecting both processes, 
although it is also possible that the loss of receptor stability following MASK 
knockdown may result in the breakdown of existing dimers as a prelude to 
protein destruction. 
While transmembrane proteins destined for insertion into the plasma-
membrane are processed via conserved ER and Golgi pathways, it is clear 
that knockdown of MASK does not globally affect the production and/or 
trafficking of all membrane spanning proteins. Rather, the requirement for 
MASK proteins is specific to a subset of transmembrane proteins affecting 
Dome but not E-cadherin in Drosophila (Fig. 2G-I), and GP130, EPOR and 
TPOR, but not LIFR, in human HeLa cells (Fig. 4D-F). This is particularly 
interesting in the context of LIFR, since it is known to form a signalling 
complex with GP130 (Gearing et al., 1991, Gearing et al., 1992). However, it 
has been shown that addition of ligand is a key factor in inducing LIFR/GP30 
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heterodimerisation, suggesting that GP130 may be trafficked independently of 
LIFR in unstimulated cells (Giese et al., 2005). Indeed, evidence suggests 
that LIFR and GP130 can be internalised and degraded via different 
mechanisms (Blanchard et al., 2000). 
In order to obtain a mechanistic insight into the function of MASK, we also 
undertook a structure-function analysis of MASK itself. This showed that 
MASK and Dome form stable physical interactions as shown by reciprocal co-
immunoprecipitation, with this interaction being primarily mediated by the 
second, central A2 group of ankyrin domains present in MASK (Fig. 3B). 
Furthermore, we also show that the overexpression of the MASK-A1/A2 
region is able to stabilise Dome levels (Fig. 3E), suggesting that MASK:Dome 
complexes [and possibly MASK:Dome:Dome complexes] may be inherently 
more stable than Dome alone. Although largely speculative, it is possible that 
the interactions seen between Dome and both the A1 and A2 regions of 
MASK (Fig 3B) may point to a model in which one Dome receptor may bind to 
each Ankyrin domain so promoting the dimerisation and stabilisation of Dome 
dimers. Although it is formally possible that MASK alters mRNA stability, this 
physical association with Dome suggests regulation at the protein level. We 
have previously demonstrated that Dome is constitutively internalised and 
degraded via the lysosome, but not recycled to a significant degree (Fisher et 
al., 2016, Stec et al., 2013). One could therefore speculate that association 
with MASK stabilizes Dome, slowing the degradation process. 
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In humans, ANKHD1 has a paralogue on chromosome 4, named ANKRD17 
(ankyrin repeat domain 17) (Sansores-Garcia et al., 2013, Sidor et al., 2013) 
with the two proteins sharing 71% identity, with greater sequence similarity in 
the regions of ankyrin repeats and the KH domain (Poulin et al., 
2003). Strikingly, ANKRD17 has been demonstrated to physically interact with 
receptors involved in the innate immune response, and plays a role in the 
release of cytokines (Menning and Kufer, 2013) and interferons (Wang et al., 
2012). These findings serve to support our own data and suggest that 
ANKHD1 and ANKRD17 may also be acting to regulate receptor stability and 
dimerisation in humans. 
Taken together, we present the first systematic screen, which we are aware 
of, to identify the factors responsible for the dimerisation of a JAK/STAT 
pathway receptor. We characterise one of these hits, MASK, and show that it 
regulates JAK/STAT pathway activity and forms a complex with the pathway 
receptor. We show that MASK is required to maintain the stability of Dome 
protein both in vivo and in cells and may well also play a role in receptor 
dimerisation. Finally, we demonstrate the evolutionary conservation of the 
MASK homologue ANKHD1 at the sequence and functional levels. As such, 
this work provides a valuable insight into this aspect of JAK/STAT pathway 
and highlights a novel level of regulation of this important and disease-
relevant pathway. 
  
J
o
u
rn
a
l o
f 
C
e
ll 
S
c
ie
n
c
e
 
 A
c
c
e
p
te
d
 m
a
n
u
sc
ri
p
t
 Materials and Methods 
Cell culture and biochemistry 
Drosophila Kc167 cells were obtained from the Drosophila Genomics Resource 
Center (DGRC) and maintained according to standard procedures (Fisher et 
al., 2012). HeLa cells were maintained in DMEM supplemented with 10% 
serum. All cells are regularly screened for contamination. Plasmid 
transfections were carried out using Effectene (Qiagen) according to 
PDQXIDFWXUHU¶V LQVWUXFWLRQV 5HYHUVH WUDQVIHFWLRQV ZLWK VL51$ ZHUH FDUULHG
out using Lipofectamine RNAiMAX (Invitrogen) using 10nM final 
concentrations of single siRNAs (Dharmacon), targeting ANKHD1 (D-014405-
01 or D-014405-02) where comparable results in terms of knockdown 
efficiency and reduction in JAK/STAT pathway activity were seen for both, or 
non-targeting siRNA as a control, D-001210-01. Stimulation of mammalian 
JAK/STAT pathway was carried out using human recombinant oncostatin M, 
(295-OM-010, R&D systems) at a final concentration of 10ng/ml for 20 
minutes. Immunoprecipitation experiments were carried out as previously 
described (Stec et al., 2013). Proteins were separated on 4-15% TGX SDS-
PAGE precast gels (Bio-Rad) and transferred to nitrocellulose membranes.  
Drosophila RNAi screen hits were assessed for their effects on Dome protein 
levels ± although it should be noted that this assay could not distinguish 
between modulation of mRNA stability or protein turnover. Kc167 cells were 
batch transfected with Dome-FLAG, incubated for 24h, then split into 24-well 
atment, cells were lysed as 
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described. Lysates were boiled in 2x Laemmeli sample buffer and analysed 
by western blotting. FLAG/tubulin fold-changes were calculated for each RNAi 
condition in comparison to the average of three negative controls per gel. 
Each screen hit was analysed blind in duplicate. 
Genome-wide RNAi screening 
The genome-wide SRSFv1 library, in 384-well format, was used as previously 
described (Fisher et al., 2012). Controls were manually added into empty 
wells (250ng dsRNA in 5ul water): GFP and the C.elegans gene baring no 
sequence homology in Drosophila, zk686.3, were used as baseline controls; 
technical controls targeting transfected plasmids were dome, LacZ and RLuc, 
and Rab5 was used as a positive control. Genome-wide screening was 
carried out in biologically independent triplicates. Kc167 cells were batch-
transfected in T75 flasks with 4µg pAc-Dome-LacZ-ǻD, pAc-Dome-LacZ-ǻZ 
and pAc-RLuc and incubated for 24h. Cells were pooled in serum-free media, 
and 15,000 cells seeded per 384-well. After 1h, media was added to a final 
10% serum concentration. After 5d cells were assayed for ȕ-gal activity using 
ȕ-glo Assay System (Promega), which involves a Firefly luciferase reactions 
(FL), followed by measurement of Renilla luciferase (RL) activity as a viability 
control. Luciferase activities were measured on a Varioskan plate reader 
(Thermo). Raw data will be made available on request. 
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Data analysis 
Firefly and Renilla luciferase values for each well were processed using the 
CellHTS2 Bioconductor package (Boutros et al., 2006). Values were median 
centred to normalise for plate-to-plate variation. Ratios of luciferase (FL/RL) 
were used to calculate the robust Z-scores, which were considered significant 
 RU -2.5. Individual FL and RL values were also assessed, since they 
were not always linear with respect to one another. Secondary analyses were 
carried out with newly synthesised dsRNAs and hits were considered 
VLJQLILFDQW DW WKH OHVV VWULQJHQW  RU -2. Forty-three robust hits were 
selected at this stage and sequenced to confirm correct target genes. 
Drosophila genotypes 
Figure 2 
D) w, GMR-updǻ¶Z1118 
E) w, GMR-updǻ¶VWDW(397/+ 
F) w, GMR-updǻ¶0$6.10.22/+ 
G,H) w UbxFLP ;;UAS-Dome-V5 FRT82 MASK7.29 / tub-GAL4 FRT82 Ubq-
GFP 
I) w UbxFLP ;;UAS-Dome-V5 FRT82 MASK10.22 / tub-GAL4 FRT82 Ubq-GFP 
 
MASK alleles were a gift of M Simon (Smith et al., 2002). 
 
Drosophila phenotypes 
Eye overgrowth assays were double blind scored alongside stat92E and w1118 
out-crosses (n>20 flies per genotype with >2 repeats). Adult flies were 
photographed using a Nikon SMZ1500 stereo-microscope and Nikon 
Elements extended depth of focus software package. 
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Wing discs were dissected from wandering 3rd instar larvae raised at 25 °C. 
Inverted carcasses were fixed in 4% paraformaldehyde in PBS for 20min, 
blocked and incubated in primary antibodies overnight at 4°C. Tissues were 
washed in PBS containing 0.2% Triton X-100 (PBST) and incubated in 
secondary antibodies overnight at 4°C. After washing, discs were mounted in 
mounting media and imaged on Nikon A1R GaAsP confocal microscope using 
a 60x NA1.4 apochromatic lens, with a pixel size of 70 nm, and the pinhole 
was set to 1.2 AU. 
Antibodies 
For western blotting all primary antibodies were used at 1:1000 dilutions: 
ANKHD1 (Sigma, HPA008718), ȕ-actin (Abcam, ab8226), GP130 (Cell 
Signaling Technologies, 3732), pSTAT1 (Cell Signaling Technologies, 9167), 
STAT3 (Cell Signaling Technologies, 12640), pSTAT3 (Cell Signaling 
Technologies, 9145), FLAG (M2, Sigma), HA (3F10, Roche), Drosophila Į-
tubulin (DM1A, Sigma). For immunohistochemistry, primary antibodies were 
E-cadherin (dCAD2, DSHB, 1:20) and V5 (E10/V4RR, Invitrogen, 1:500). 
Cloning of expression constructs 
Dome-LacZ-ǻĮ -ǻȦ fragments were cut from pUAST vectors (Brown et 
al., 2003) and ligated into pAc5.1 vector (Invitrogen) using KpnI and XbaI 
restriction sites (partial digestion of KpnI sites used for 'Z). pAc-Dome-FALG 
and pAc-Dome-HA were described in (Stec et al., 2013). Drosophila MASK-
A1/A2 was PCR amplified from cDNA clone LD31446 (DGRC). Gateway 
cloning of PCR product was carried out using the pENTR/D-TOPO Cloning Kit 
(Invitrogen) and introduced into the pAWF vector (Drosophila Gateway Vector 
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Collection) using Gateway LR Clonase II Enzyme Mix (Invitrogen), according 
WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV +$-MASK constructs were a gift from G 
Halder (Sansores-Garcia et al., 2013). 
Quantitative real-time PCR 
Total RNA was extracted from cells using TRIZOL Reagent (Invitrogen) 
IROORZLQJ PDQXIDFWXUHU¶V LQVWUXFWLRQV 6\QWKHVLV RI F'1$ ZDV FDUULHG RXW
using High Capacity RNA-to-cDNA Kit (App
RNA. To confirm gene knockdown by RNAi or to measure levels of target 
gene expression, qPCR was carried out using SsoAdvanced SYBRGreen 
Supermix (BioRad) on a CFX-96 Touch new generation Real-Time PCR 
Detection System (BioRad). Change in expression levels between 
experimental conditions was calculated compared to housekeeping gene 
expression (either Drosophila 5S/ RU KXPDQ ȕ-DFWLQ XVLQJ WKH ǻǻ&T 
method (Bina et al., 2010). Statistical analysis was carried out using one-way 
ANOVA tests in Prism (Graphpad). Primers are listed in Table S2. TAQMAN 
qPCR probes were designed for multiplexing (IDT oligo). 
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)LJXUH$VSOLWȕ-galactosidase genome-wide RNAi screen for 
modulators of Dome dimerisation and levels. 
A) Schematic representation of the Dome-ȕJDOǻĮDQG'RPH-ȕJDOǻȦ 
complementation assay. PM = plasma membrane. 
B) Drosophila Kc167 cells transiently transfected with plasmids expressing the 
SURWHLQVVKRZQLQ$VKRZȕ-galactosidase activity by X-gal staining. 
C) Workflow of the genome-wide RNAi screen for modulators of Dome 
dimerisation and levels as undertaken in Drosophila Kc167 cells.  
D) Ranked Z-scores from the genome-wide RNAi screen. Green lines 
illustrate Z-score cut-offs of significant increase or significant decrease. 
Controls are shown with MASK highlighted in red. 
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Figure 2. MASK regulates pathway activity and receptor levels in vivo 
A) Co-expression of Dome-HA and Dome-FLAG followed by Dome-HA 
immunoprecipitation in Drosophila Kc167 cells. Levels of co-precipitated Dome-
FLAG are modulated by treatment with the MASK dsRNA. 
B) Quantification of steady state Dome-FLAG protein levels expressed by 
Kc167 cells after knockdown of MASK. Number indicates fold change, error 
bars show standard deviation, p-YDOXHLVLQGLFDWHGIURP6WXGHQW¶VW-test (n=3). 
C) Expression of the JAK/STAT pathway target gene SOCS36E following 
Upd2 ligand stimulation and treatment with indicated dsRNAs. Error bars 
show standard deviation (n=3), ** p < 0.01, *** p < 0.001 (One-way ANOVA 
ZLWK'XQQHWW¶VSRVWKRFWHVW 
D-F) Dorsal view of eye overgrowth phenotypes caused by ectopic Upd ligand 
expression driven by GMR-8SGǻ¶ Loss of one copy of STAT92E or MASK 
suppresses overgrowth. 
G) Mitotic clones of MASK7.29 caused a reduction in tubulin-GAL4 driven UAS-
Dome-V5 (red) fluorescence, whereas E-cadherin (blue) levels were 
unaffected. Clones were identified using loss of native GFP (green). 
H-I) Quantification of Dome-V5 and E-cad levels in MASK7.29 (H) or MASK10.22 
(I) mutant clones. Ratios of fluorescence intensity inside clones and in nearby 
twin-spots were taken to control for variations across discs. Measurements 
ZHUHDYHUDJHGRYHUGLVFVZLWKDWOHDVWFORQHVSHUGLVFp < 0.01, *** p 
< 0.001 (One-sample t-test with expected mean of 1). 
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Figure 3. MASK physically associates with Dome. 
A) Schematic representation of Drosophila MASK protein and constructs used 
in this study. 
B) Immunoprecipitation of the indicated HA-MASK constructs from Kc167 cells 
also expressing Dome-FLAG. Dome-FLAG is co-immunoprecipitated with HA-
MASK-A1 and HA-MASK-A2. Levels of Dome-FLAG present in the input 
lysate are shown. NS = non-specific band. 
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C) Co-precipitation of MASK-A1/A2-FLAG following immunoprecipitation of 
Dome-HA. Levels of MASK-A1/A2-FLAG, Dome-+$DQGĮ-Tubulin present in 
the total Kc167 cell lysates are shown. 
D) Steady state levels of Dome-FLAG expressed in Drosophila Kc167 cells are 
increased following the co-expression of HA-MASK-$/HYHOVRIĮ-Tubulin 
indicate loading parity. 
E) Steady state levels of MASK-A1/A2-FLAG expressed in Drosophila Kc167 
cells are increased following the co-expression of Dome-HA. /HYHOVRIĮ-
Tubulin indicate loading parity. 
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Figure 4. MASK function is conserved to human cells 
A) Schematic representation of protein structure of Drosophila MASK and 
human ANKHD1 with % identity between sequences.  
B) SOCS3 mRNA expression in HeLa cells transfected with indicated siRNA 
and following OSM stimulation as indicated. *** p < 0.001 (One-way ANOVA 
ZLWK'XQQHWW¶VSRVWKRFWHVW 
C) HeLa cell extracts treated with siRNA targeting ANKHD1 have reduced 
phospho-STAT3 upon OSM stimulation, which total STAT3 levels are 
unaffected. Blots confirm knockdown of ANKHD1 levels. 
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D) A representative blot of HeLa cells treated with control siRNA or siRNA 
targeting ANKHD1 in (n=3). Silencing of ANKHD1 leads to a loss of both 
ANKHD1 protein and endogenous GP130 protein. By contrast, levels of LIFR 
DUHQRWFKDQJHGȕ-actin levels are unaffected. 
E-F) HeLa cell extracts treated with siRNA targeting ANKHD1 have reduced 
HA-EpoR (G) and TpoR-HA (H) compared to controls. Blots confirm 
knockdown of ANKHD1 levels. 
  
J
o
u
rn
a
l o
f 
C
e
ll 
S
c
ie
n
c
e
 
 A
c
c
e
p
te
d
 m
a
n
u
sc
ri
p
t
 Table 1. Secondary screens confirm 43 robust hits. 
After secondary screening with Dome receptor assay, 43 candidates were 
found to be reproducible hits (see Table S1 and Materials and Methods for 
further details). Two genes are listed twice, since independent dsRNAs for 
these were present within the genome plates and taken through to secondary 
screens. Rab5 was also identified, even though this was used as a positive 
control. To prove the effectiveness of the STAT reporter assay, we have 
included results from knockdown of Hop, STAT92E and SOCS36E. Results 
for MASK are shown in bold. Numbers for receptor dimerisation and STAT 
reporter assays are shown as Z-scores. Dome protein levels are shown as 
fold-change relative to controls. 
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Table 1 
Symbol Receptor dimerisation assays 
 STAT 
reporter 
assay 
 Total 
Dome 
protein  Genome  -Upd  +Upd       
Assay: ȕ-gal 
 
viability 
 
ratio 
 
ratio 
 
ratio 
 
ratio 
  
Receptors: D:D 
 
    D:D 
 
D:D 
 
D:L 
 
L:L 
  CG40121 -6.0   1.6   -8.5   -5.4   -6.5   2.3   -2.3  1 
Tor -5.9   0.3 
  
-2.2   -2.9   -2.6   -3.0   0.7   0.6 
MASK -2.8   4.5 
  
-5.5   -3.5   -3.3   -5.2 
 
-4.3   0.75 
CG7277 -4.4   1.2 
  
-4.1   -2.8   -3.2   0.4   -0.2   0.7 
Mi-2 -3.0   2.6 
  
-3.7   -0.8   -2.1   -3.5   2.0   0.3 
CG31689 -4.5   0.2 
  
-8.4   -4.1   -8.3   -11.5   0.1   1 
Eaf -3.1   1.3 
  
-3.0   -1.8   -3.4   -5.5   -0.8   0.7 
Sec61beta -2.9   1.4 
  
-2.6   -2.0   -2.6   -4.4   0.4   1 
CheB38c -4.0   -0.4 
  
-3.3   -1.6   -3.5   -4.9   0.4   0.9 
Clamp -4.2   -0.8 
  
-2.9   -2.1   -3.0   -3.7   1.7   0.8 
upSET -2.6   1.6 
  
-2.6   -0.4   -1.8   -2.7   1.3   0.9 
CkIalpha -3.4   0.3 
  
-2.1   -1.7   -2.4   -4.0   5.9   0.9 
angel -3.5   0.2 
  
-3.5   -2.2   -2.9   -2.3   -0.4   1.1 
CG6106 -3.4   0.1 
  
-5.3   -3.1   -5.3   -6.2   0.9   1 
Hcf -3.4   -0.1 
  
-3.6   -2.9   -1.7   -1.8   0.1   0.6 
Mtor -3.0   0.3 
  
-2.5   -0.9   -2.8   -4.3   1.0   0.7 
GalNAc-T2 -3.5   -0.6 
  
-3.1   -1.5   -3.9   -4.1   1.1   0.6 
Jra -2.5   0.7 
  
-3.9   -0.9   -5.3   -8.8   -0.6   0.6 
lig3 -2.9   0.1 
  
-2.3   -2.4   -2.8   -3.5   -0.2   1.1 
CG14455 -2.4   0.6 
  
-2.6   -1.1   -2.2   -3.1   0.6   1 
tup -3.0   -0.3 
  
-2.1   -2.5   -2.2   -2.4   1.1   0.7 
Fur1 -3.2   -0.6 
  
-2.5   -0.9   -1.4   -1.0   -1.9   0.4 
Amt -3.0   -0.8 
  
-4.3   -3.4   -3.5   -1.1   -1.2   0.5 
trr -3.2   -1.9 
  
-4.7   -2.5   -3.7   -5.1   1.2   0.8 
CG34114 -2.8   -1.2 
  
-3.3   -1.4   -3.1   -5.7   0.3   0.5 
CG11399 -6.1   -7.0 
  
-6.2   -3.5   -5.6   -8.2   3.3   0.3 
CG11399 -1.2   -0.4 
  
-2.0   -0.7   -2.2   -2.8   0.8   1 
eff 3.3   3.3 
  
2.6   3.2   2.1   1.7   3.8   1.3 
EbpIII 3.1   2.1 
  
4.7   6.5   5.6   9.3   0.7   1.8 
SCAR 3.5   2.3 
  
3.1   5.6   3.6   6.0   1.4   2.5 
Act87E 2.7   0.4 
  
4.5   3.8   5.3   12.8   -0.4   3.2 
CG16772 3.0   0.3 
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eff 3.6   1.0 
  
1.4   3.4   1.6   0.3   2.1   2.1 
alphaTub84B 4.0   0.5 
  
4.1   3.3   4.5   11.0   0.5   3 
Dp 4.0   0.8 
  
5.8   2.8   4.4   13.1   -1.2   5.3 
Sin 3.5   -0.7 
  
4.0   5.8   4.5   7.2   0.7   1.1 
Clk 5.0   1.3 
  
2.1   3.3   2.2   2.1   -0.3   3.4 
ball 3.6   -1.2 
  
4.0   3.6   4.9   11.2   0.1   2.6 
shi 4.7   -0.1 
  
4.0   4.4   4.0   4.8   1.9   1.5 
cpa 4.9   0.2 
  
4.0   2.9   3.6   8.4   0.1   2.8 
Act42A 6.5   0.8 
  
10.0   7.0   9.6   18.9   -0.5   4.1 
PGRP-SC2 6.5   0.1 
  
8.7   5.4   7.8   16.5   0.1   9.9 
Rab5 6.7   0.1   5.5   5.6   5.2   7.5   2.0   3.4 
Act5C 7.6   0.8 
  
8.4   7.2   10.0   18.3   0.3   3.9 
CG4511 6.9   -0.8 
  
6.5   4.3   5.1   10.5   -0.1   10 
tsr 7.5   -0.3 
  
10.2   7.1   9.6   16.9   0.3   9.5 
                                
hop 0.5   0.2   0.0   -0.7   0.0   -0.1   -7.4   1 
Stat92E 0.1   -0.6   0.7   -0.6   0.2   0.2   -7.0   0.8 
Socs36E 1.2   -0.2   -0.5   -1.2   -1.0   -1.0   4.7   0.9 
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Figure S1. A) A significant increase in β-gal activity is observed in cells co-transfected with both plasmids 
(4), compared to cells transfected with individual plasmids and mixed together (3), demonstrating the 
specificity of the assay. B) Box-and-whisker plots showing Z-scores of negative control RNAi (C.elegans 
gene ZK686.3 or GFP) show little variation from the median, whereas technical positive RNAi controls, 
targeting the transfected plasmids (Dome, LacZ, RLuc) show significant Z-scores. Further positive control 
(Rab5), targeting the endocytic machinery and causing an increase in Dome stability, shows a significant 
increase in enzyme activity. C-D) Example western blot (C) and quantification (D) from secondary RNAi 
screen analysis, measuring Dome protein levels. E) Dome-FLAG protein levels increase in Kc167 cells upon 
knockdown of Act42A, resulting in a 2.5-fold increase compared to a LacZ control. F) qPCR of the Dome-
FLAG construct also shows an approximately 2.5-fold increase in expression upon knockdown of Act42A. 
Efficiency of RNAi is confirmed by qPCR of Act42A. 
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Figure S2. A) mRNA expression levels of MASK in Kc167 cells assayed by qPCR after indicated RNAi 
treatment (MASK1= BKN20625; MASK2 = HFA16018) relative to housekeeping gene RpL32. Knockdown 
of MASK levels are confirmed. *** p < 0.01. B) 6x2xdRafluc STAT92E reporter assay is reduced after 
indicated RNAi treatment. C) Three different STAT92E-dependent luciferase reporters were used to 
measure JAK/STAT activity after stimulation with Upd. Significant changes were observed after indicated 
RNAi treatment for all STAT92E-dependent reporters. D) Z-scores derived from the Dome dimerisation 
genome-scale RNAi screen comparing the effect of MASK knockdown (column 1) to the Ras/Raf pathway 
components csw, Ras85D, Ras64B, raf and for the Hipo pathway genes hpo, wts and yki. None of the 
interactions were significant (ns). E) Z-scores derived from a previous genome-scale RNAi screen for 
modulators of the 6x2xDrafLuc STAT92E activity reporter {Fisher et al., 2012, BMC Genomics, 13, 506}. 
The effect of MASK (column 1) is compared to the Ras/Raf pathway genes csw, Ras85D, Ras64B, raf and 
to the Hippo pathway genes hpo, wts, yki. None of the interactions were significant (ns). F-H) Dorsal view 
of eye overgrowth phenotypes caused by ectopic Upd ligand expression driven by GMR-UpdΔ3Õ. Panels 
show an alternative control (OreR), which was scored as normal, and two further MASK alleles (MASK5.8
and MASK7.29), which were scored as having moderate suppression. 
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Figure S3 
A) mRNA expression of ANKHD1 indicated from HeLa cells, after siRNA treatment of ANKHD1or non-
targeting control. Measurements were taken relative to β-actin. 
B) phospho-STAT1 (pSTAT1) and phospho-STAT3 (pSTAT3) protein are increased by ligand stimulation
(OSM) in HeLa cells treated with control siRNA. Induction of phosphorylated STATs was suppressed when 
treating cells with non-overlapping siRNA reagents targeting ANKHD1. β-actin was used as a loading 
control. 
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